1989 founded company to offer Anti Viral Tablets, Automatic External Defibrillator and more!
About Us

Being one of leading and reputed manufacturers of medical equipment and pharmaceutical products, we, Zhejiang Huahai Pharmaceutical Co. Limited, offer Cardiovascular Tablets, Anti Viral Tablets, Automatic External Defibrillator and more, of uncompromising quality at the competitive prices.

Our company, as a well-recognized Chinese pharmaceutical entity, have expanded our operations to be an exporter, as well. Thus, setting benchmarks for quality and effectiveness of our offerings at International platform. Moreover, by rendering Amisulpride API Intermediates Services and Carbidopa API Intermediates Services as a service provider, we have been increasing global trade for API, an effort that Chinese Pharmaceutical Industry has been constantly striving to accomplish. In addition, we provide Contract Manufacturer Organization Services to our clients within the committed time frame that too without compromising on quality.

Our offerings are available in 30 cities and provinces across China, thereby, carefully fulfilling our responsibility of ensuring easy access to cost-effective healthcare products to public.

Milestones

  • The increasing demands of our customers made us set 40 plus subsidiaries of our company.
  • Our dedication to work has made us establish strong bonds with over 500 cooperative partners.
  • We are backed by 7000 staff members who remain on their feet to accomplish our set targets on-time.
  • With our widespread logistics network, we have been supplying our offerings across 200 plus supply locations.

Company Culture

Mission: Serve Society and Care for Human Life

The foundation of our company is set over our mission of serving society and care for life. Our mission motivates our people.

Our unwavering commitment to offer quality-marked Anti Viral Tablets, Automatic External Defibrillator and more, ensures better health of people. Therefore, our staff devote their time and energy in creating great value for our society, esteemed customers, and other business partners.

Our Vision: Set Benchmarks as Renowned Pharmaceutical Company Worldwide

Our vision is deeply entrenched in our mission. We have always remained confident in realizing this as our vision with the dedication of our employees.

Core Values: Innovation and Quality

Quality has always been the focal point of our business and innovation drives it. With these two as our founding stones, we have been achieving tremendous success.

Business ethics define our offerings including Automatic External Defibrillator and Carbidopa API Intermediates Services.

Enterprise Spirit: Excellence, Ambition, Solidarity and Endeavor

The development of our company is driven by the factors like excellence, ambition, solidarity and endeavor. These factors are immensely rooted in the culture of our company and all our employees overcome all the business challenges with their focus on these factors for achieving our vision and mission.

Innovation- Result of Research Practices

Since inception, we have been adhering to innovation driven business development and built an R&D system, which has strong capabilities and help us have collaborations with academic & research institutions and companies. Therefore, we always come up with Anti Viral Tablets, Cardiovascular Tablets, and other allied pharmaceutical products. In order to revitalize the pharmaceutical industry, our this department works towards attracting & retaining international pharmaceutical talents.

Our company has developed its integrated R&D system in Shanghai, United States and Linhai. The department works towards ensuring collaborations and right utilization of its resources. Currently, over 400 experts, who have PhD or master degree are associated with our R&D work.

Multi-level R&D Institutions

As an innovation and technology focused company of China, we have set a national enterprise technology center with a national post-doctoral scientific research station. The established center is recognized by 5 ministries/commissions of China. With its support, we have been providing our customers qualitative line of Cardiovascular  Tablets, Amisulpride API Intermediates Services and more.

Multi-Form Multi-level R&D Cooperation

To support the innovation platform of our company, we have established four pillars for ourselves. We have made collaborations with over 20 scientific research institutes, colleges and universities to have information about new and better products developments and techniques.

We associated with Shanghai Tongji University on 14th January, 2015 for building Institute of Environmental Protection and Environmental Protection Postdoctoral Workstation and Engineering Research.

South Korean Eutilex and our company reaches at strategic cooperation.

Research and Development Results

Tabulated below are the milestones we have achieved in R&D domain:

Year

Milestone

2013

  • Due to research, development & industrialization work of green-key technologies for anti-hypertension sartan pharmaceuticals, we won the first prize for Scientific & Technological Progress of Shanghai Municipality.

2014

  • For adopting excellent methods of preparing 2-carbonitrile biphenyl derivatives, we have won Excellence Award for Patents of China.
  • Because of excellent to research, development & industrialization work of green-key technologies for anti-hypertension sartan drugs, our company again won the prize for Scientific & Technological Progress of Shanghai Municipality, this was our second award.
  • The excellent quality work we did for research, development and industrialization of purification & crystallization technologies for high-end pharmaceutical products, made us win First Prize for Scientific & Technological Progress of Tianjin Municipality.

2015

  • Our work for high-end pharmaceutical products in the field of research, development and industrialization of purification & crystallization technologies made us grab Second Prize of National Science & Technology Progress Award.
  • We started supplying topiramate tablets, olanzapine orally disintegrating tablets and pregabalin capsules.
  • We got approval for clinical trials of pregabalin capsules.
  • We got approval for clinical trials of olanzapine orally disintegrating tablets as well.

2016

  • In this year, our company got approval for clinical trials of its topiramate tablets.
  • Our company received approval for clinical trials of ambrisentan tablets.
Get in touch with us
RFQ Request For Quotation
Get Quotes For Your Buying Requirement. Tell Suppliers What You Need.
I agree to abide by all the Terms and Conditions of tradeindia.com